FIELD: medicine.
SUBSTANCE: group concerns using undecapeptide - H-Tyr-Pro-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-Gly-OH·9HCl as an analgesic agent. The group of inventions also concerns a dosage form containing the above peptide as an active substance for treating acute and chronic pain syndromes.
EFFECT: stable and prolonged analgesic effect both in the enteral, and oral route of administration.
3 cl, 2 ex, 2 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANALGESIC AGENT OF PEPTIDE STRUCTURE BASED ON TRIDECAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2538727C1 |
| FAMILY OF PEPTIDES POSSESSING ANALGESIC ACTIVITY | 2005 |
|
RU2286169C1 |
| PEPTIDE FOR MEDICAL TREATMENT OF PANCREATIC DIABETES OF 2ND TYPE AND ITS COMPLICATIONS | 2014 |
|
RU2573933C1 |
| METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
| AGENT OF PEPTIDE STRUCTURE, INHIBITING DIPEPTIDYL PEPTIDASE-4, AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2015 |
|
RU2589258C1 |
| HYPOGLYCEMIC AGENT OF PEPTIDE STRUCTURE INHIBITING DIPEPTIDYL PEPTIDASE-4 | 2015 |
|
RU2600810C1 |
| PEPTIDE DERIVATIVES AND METHOD OF THEIR PRODUCTION | 1992 |
|
RU2087480C1 |
| ANALOGUE OF ALPHA-CONOTOXIN RGIA FOR TREATING PAIN | 2016 |
|
RU2731217C2 |
| INHIBITORS OF XA FACTOR | 1995 |
|
RU2152954C1 |
| OXYTOCIN RECEPTOR AGONISTS | 2010 |
|
RU2539692C2 |
